1,312
Participants
Start Date
December 31, 2003
Primary Completion Date
November 30, 2004
lumiracoxib
Novartis Investigative Site, Malvern
Novartis Investigative Site, Vienna
Novartis Investigative Site, Prague
Novartis Investigative Site, Turku
Novartis Investigative Site, Dresden
Novartis Investigative Site, Budapest
Novartis Investigative Site, Haifa
Novartis Investigative Site, Lisse
Novartis Investigative Site, Rotorua
Novartis Investigative Site, Poznan
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Johannesburg
Novartis Investigative Site, Seville
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Izmir
Lead Sponsor
Novartis
INDUSTRY